Interferon maintenance for prevention of relapse in favorable risk AML?

Sara H. Small*, Jessica K. Altman, Leonidas C. Platanias

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)2818-2819
Number of pages2
JournalLeukemia and Lymphoma
Issue number12
StatePublished - 2021

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this